Unstable angina and NSTEMI: Are you up to date?

Emergency Medicine

Volumn 40, Issue 10, 2008, Pages

  Cunningham, Michael C ^e   Reilly, John P ^a,b   Lavie, Carl J ^c,d   Sundell, Erik T ^d  

^a Cardiac Catheterization Laboratory

^b Cardiovascular CT

^c STANFORD UNIVERSITY   (United States)

^d OCHSNER CLINIC FOUNDATION   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56549096655     PISSN: 00136654     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Anderson JL, et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116(7):e148, 2007.
2. Antman EM, et al.: The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284(7):835, 2000.
3. Aviles RJ, et al.: Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346(26):2047, 2002.
4. Chen ZM, et al.: Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction; randomised placebo-controlled trial. Lancet 366(9497):1607, 2005.
5. Chen ZM, et al.: Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366(9497):1622, 2005.
6. Fesmire FM, et al.: The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes. Ann Emerg Med 40(6):584, 2002.
7. Galvani M, et al.: N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 110(2):128, 2004.
8. Hochholzer W, et al.: Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 111(20):2560, 2005.
9. Kastrati A, et al.: Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295(13):1531, 2006.
10. Lüscher MS, et al.: Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation 96(8):2578, 1997.
11. Newby LK, et al.: Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 98(18):1853, 1998.
12. Roger VL, et al.: Redefinition of myocardial infarction: prospective evaluation in the community. Circulation 114(8):790, 2006.
13. Rosamond W, et al.: Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69, 2007.
14. Sabatine MS, et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352(12):1179, 2005.
15. Stone GW, et al.: Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355(21):2203, 2006.
16. von Beckerath N, et al.: Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 112(19):2946, 2005.
17. Young GP, et al.: Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study. Acad Emerg Med 4(9):869, 1997.
18. Yusuf S, et al.: Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354(14):1464, 2006.
19. Zipes DP and Braunwald E: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed. WB Saunders, 2005, pp. xxi, 2183, 75.